Garzon, Ramiro <br/><br/>
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.  [electronic resource] 

 -  Blood  06 2017 
 - 3165-3174 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2016-11-750158  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blast Crisis--blood<br/>Bone Marrow Cells--metabolism<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Hydrazines--administration & dosage<br/>Leukemia, Myeloid, Acute--blood<br/>Male<br/>Middle Aged<br/>Survival Rate<br/>Triazoles--administration & dosage